tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Revenue

Compare
0 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had a revenue of 19.77B in the quarter ending Sep 30, 2025, with 2.09%. This bring the company's revenue in the last twelve months to 77.53B, Decreased 2.31%. In the fiscal year ending Dec 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B with -0.69% growth.
Revenue (ttm)
77.53B
Revenue Growth
1.13%
P/S Ratio
0.59
Revenue/Employee
HK$2,665,179
Employees
28,138
Market Cap
HK$44.07B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
74.99B-522.58M+99.31%
Dec 31, 2023
75.52B4.73B+106.68%
Dec 31, 2022
70.79B1.77B+102.57%
Dec 31, 2021
69.01B7.34B+111.90%
Dec 31, 2020
61.67B-3.28B+94.95%
Dec 31, 2019
64.95B22.72B+153.79%
Dec 31, 2018
42.23B21.28B+201.55%
Dec 31, 2017
20.95B